1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Dabrafenib 75 MG: new trials by email Literature Review of Dabrafenib 75 MG trials Research Report on Dabrafenib 75 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) Dabrafenib 75 MG, Trametinib 2 MG - Thyroid Cancer | Phase 2 | Unknown | Olivia Newton-John Cancer Research Institute | 80 | 2022-07-14 | 2023-10-31 |
Olivia Newton-John Cancer Research Institute (1)
Australia (1)